 INmune Bio, Inc. INMB, a clinical-stage immunology company focused on developing treatments that harness the patients innate immune system to fight disease, today announced that it will host a conference call on May 14, 2020 at 4:30 PM Eastern Time to discuss results for its first quarter ended March 31, 2020. INmune Bio, Inc. is a publicly traded INMB, clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease. 